Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.

scientific article published on 15 November 2017

Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJSO.2017.10.216
P698PubMed publication ID29258720

P2093author name stringA D R Huitema
H Boot
N F M Kok
A G J Aalbers
K Woensdregt
W J van Eden
P433issue2
P921main subjectcolorectal cancerQ188874
oxaliplatinQ422327
peritoneal carcinomatosisQ2071182
P304page(s)220-227
P577publication date2017-11-15
P1433published inEuropean Journal of Surgical OncologyQ2345728
P1476titleSafety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
P478volume44

Reverse relations

cites work (P2860)
Q97094754A one-pot process for synthesis of mitomycin analogs catalyzed by laccase/lipase optimized by response surface methodology
Q92497479Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
Q92722685Effect of intraperitoneal chemotherapy concentration on morbidity and survival
Q92463681Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature
Q91749747Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure
Q60912302Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study
Q92737596Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
Q64087322Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, r
Q61795888Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review

Search more.